Virinchi Limited has signed a multi-product five-year contract with Advance America Inc for a period of five years. Advance America Inc is the largest company in the US in the alternate finance industry which delivers, maintains and hosts its flagship lending management software.

Steel Strips Wheels Limited (SSWL) has secured another big export order for supply of Steel wheels to the EU Caravan market.

For fiscal year 2018, Infosys’ revenues in dollar terms grew by 7.2 per cent which seems to be in line with company’s guidance of 6.5 to 7.5 per cent. Further, in constant currency terms, revenues increased by 5.8 per cent in line with guidance of 5.5 to 6.5 per cent.

Strides Shasun’s wholly-owned subsidiary Strides Pharma Global Pte. Ltd. has received approval for Cyproheptadine Hydrochloride Tablets from the United States Food & Drug Administration (USFDA), keeping its ANDA approval momentum intact.

Jindal Steel and Power Limited (JSPL) has posted highest ever monthly crude steel production for the month of March 2018 at 0.45MT, almost jumped by 55 per cent. For Q4FY18, it has reported production of 1.26MT, registering jump of 38 per cent.

These orders are for construction of proposed residential rehabilitation and sale of tower amounting to Rs. 145.50 crore and for construction of mixed use development project amounting to Rs. 220 crore.

Auto majors reported quite impressive sales numbers for March 2018 and FY18. Cheering these sales numbers, Nifty Auto touched a high of 11,010.30, almost up by 2 per cent.

BHEL has forayed into lake purification under the Smart City programme with an order from Raipur Smart City Limited (RSCL). This initiative is a part of its diversification strategy through continuous focus on water business.

KEC International, an RPG Group Company, has bagged new orders totalling Rs. 2,419 crore. The turnkey order includes construction of GIS substations in Tamil Nadu, Karnataka and Bihar.

Suven Life Sciences secured product patents from Norway, South Korea and Singapore regulators corresponding to the New Chemical Entities (NCEs) for the treatment of disorders allied with Neurodegenerative diseases.